The effect of rat strain, diet composition and feeding period on the development of a nutritional model of non-alcoholic fatty liver disease in rats

Physiological Research

Volumn 60, Issue 2, 2011, Pages 317-328

  Kucera O ^a   Garnol, T ^a   Lotkova H ^a   Stankova P ^a   Mazurova Y ^a   Hroch, M ^a   Bolehovska R ^a   Rousar T ^a   Cervinkova Z ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cytokines; Fatty liver; Oxidative stress

Indexed keywords

EID: 79959277180     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.932022     Document Type: Article

References (55)

1. AHMED U, REDGRAVE TG, OATES PS: Effect of dietary fat to produce non-alcoholic fatty liver in the rat. J Gastroenterol Hepatol 24: 1463-1471, 2009.
2. AKBIYIK F, CINAR K, DEMIRPENCE E, OZSULLU T, TUNCA R, HAZIROGLU R, YURDAYDIN C, UZUNALIMOGLU O, BOZKAYA H: Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver. Eur J Clin Invest 34: 429-435, 2004.
3. ALLISTER EM, BORRADAILE NM, EDWARDS JY, HUFF MW: Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes. Diabetes 54: 1676-1683, 2005.
4. AVNI Y, SHIRIN H, AEED H, SHAHMUROV M, BIRKENFELD S, BRUCK R: Thioacetamide-induced hepatic damage in a rat nutritional model of steatohepatitis. Hepatol Res 30: 141-147, 2004.
5. BARNARD RJ, ROBERTS CK, VARON SM, BERGER JJ: Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J Appl Physiol 84: 1311-1315, 1998.
6. BERRY MN, CLARK DG, GRIVELL AR, WALLACE PG: The contribution of hepatic metabolism to diet-induced thermogenesis. Metabolism 34: 141-147, 1985.
7. BLIGH EG, DYER WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
8. BUETTNER R, PARHOFER KG, WOENCKHAUS M, WREDE CE, KUNZ-SCHUGHART LA, SCHÖLMERICH J, BOLLHEIMER LC: Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 36: 485-501, 2006.
9. BUSTAMANTE E, SOPER JW, PEDERSEN PL: A high-yield preparative method for isolation of rat liver mitochondria. Anal Biochem 80: 401-408, 1977.
10. CUMMINGS MH, WATTS GF, UMPLEBY AM, HENNESSY TR, KELLY JM, JACKSON NC, SÖNKSEN PH: Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetes 44: 1059-1065, 1995.
11. DAY CP, JAMES OF: Steatohepatitis: a tale of two "hits" ? Gastroenterology 114: 842-845, 1998
12. DRAHOTA Z, KŘIVÁKOVÁ P, ČERVINKOVÁ Z, KMONÍČKOVÁ E, LOTKOVÁ H, KUČERA O, HOUŠTEK J: Tert-butyl hydroperoxide selectively inhibits mitochondrial respiratory-chain enzymes in isolated rat hepatocytes. Physiol Res 54: 67-72, 2005.
13. DUPLUS E, GLORIAN M, FOREST C: Fatty acid regulation of gene transcription. J Biol Chem 275: 30749-30752, 2000.
14. ECHTAY KS, ESTEVES TC, PAKAY JL, JEKABSONS MB, LAMBERT AJ, PORTERO-OTÍN M, PAMPLONA R, VIDAL-PUIG AJ, WANG S, ROEBUCK SJ, BRAND MD: A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J 22: 4103-4110, 2003.
15. ERICKSON SK: Nonalcoholic fatty liver disease. J Lipid Res 50 (Suppl): S412-S416, 2009.
16. FARRELL GC: Animal models of steatohepatitis. In: Fatty Liver Disease: NASH and Related Disorders. GC FARRELL, J GEORGE, DE LA M HALL P, MC CULLOUGH AJ (eds), Backwell Publishing, Malden, MA, 2005, pp 91-108.
17. FEILLET-COUDRAY C, SUTRA T, FOURET G, RAMOS J, WRUTNIAK-CABELLO C, CABELLO G, CRISTOL JP, COUDRAY C: Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: Involvement of mitochondrial and NAD(P)H oxidase systems. Free Radic Biol Med 46: 624-632, 2009.
18. FERNØ J, VIK-MO AO, JASSIM G, HÅVIK B, BERGE K, SKREDE S, GUDBRANDSEN OA, WAAGE J, LUNDER N, MØRK S, BERGE RK, JØRGENSEN HA, STEEN VM: Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology 203: 73-84, 2009.
19. FORCHERON F, ABDALLAH P, BASSET A, DEL CARMINE P, HAFFAR G, BEYLOT M: Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate. Obesity 17: 1381-1389, 2009.
20. FRANCO R, SCHONEVELD OJ, PAPPA A, PANAYIOTIDIS MI: The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 113: 234-258, 2007.
21. GAO D, WEI C, CHEN L, HUANG J, YANG S, DIEHL AM: Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am J Physiol 287: G1070-G1077, 2004.
22. GARCÍA-RUIZ I, RODRÍGUEZ-JUAN C, DÍAZ-SANJUAN T, DEL HOYO P, COLINA F, MUÑOZ-YAGÜE T, SOLÍS-HERRUZO JA: Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 44: 581-591, 2006.
23. GEORGE J, PERA N, PHUNG N, LECLERCQ I, YUN HOU J, FARRELL G: Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol 39: 756-764, 2003.
24. GHOSHAL AK, FARBER E: Choline deficiency, lipotrope deficiency and the development of liver disease including liver cancer: a new perspective. Lab Invest 68: 255-260, 1993.
25. GRATTAGLIANO I, CARACENI P, CALAMITA G, FERRI D, GARGANO I, PALASCIANO G, PORTINCASA P: Severe liver steatosis correlates with nitrosative and oxidative stress in rats. Eur J Clin Invest 38: 523-530, 2008.
26. HEGARTY BD, COONEY GJ, KRAEGEN EW, FURLER SM: Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51: 1477-1484, 2002.
27. HISSIN PJ, HILF R: A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74: 214-226, 1976.
28. JEONG WI, JEONG DH, DO SH, KIM YK, PARK HY, KWON OD, KIM TH, JEONG KS: Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats. J Vet Med Sci 67: 235-242, 2005.
29. KANĎÁR R, ŽÁKOVÁ P, LOTKOVÁ H, KUČERA O, ČERVINKOVÁ Z: Determination of reduced and oxidized glutathione in biological samples using liquid chromatography with fluorimetric detection. J Pharm Biomed Anal 43: 1382-1387, 2007.
30. KAWASAKI T, IGARASHI K, KOEDA T, SUGIMOTO K, NAKAGAWA K, HAYASHI S, YAMAJI R, INUI H, FUKUSATO T, YAMANOUCHI T: Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J Nutr 139: 2067-2071, 2009.
31. KIRSCH R, CLARKSON V, VERDONK RC, MARAIS AD, SHEPHARD EG, RYFFEL B, DE LA M HALL P: Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency. J Gastroenterol Hepatol 21: 174-182, 2006.
32. LEE GS, YAN JS, NG RK, KAKAR S, MAHER JJ: Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury. J Lipid Res 48: 1885-1896, 2007.
33. LIEBER CS, LEO MA, MAK KM, XU Y, CAO Q, REN C, PONOMARENKO A, DECARLI LM: Model of nonalcoholic steatohepatitis. Am J Clin Nutr 79: 502-509, 2004.
34. LONDON RM, GEORGE J: Pathogenesis of NASH: animal models. Clin Liver Dis 11: 55-74, 2007.
35. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
36. MALAGUARNERA M, DI ROSA M, NICOLETTI F, MALAGUARNERA L: Molecular mechanisms involved in NAFLD progression. J Mol Med 87: 679-695, 2009.
37. MCCLAIN CJ, MOKSHAGUNDAM SP, BARVE SS, SONG Z, HILL DB, CHEN T, DEACIUC I: Mechanisms of non-alcoholic steatohepatitis. Alcohol 34: 67-79, 2004.
38. NANJI AA: Animal models of nonalcoholic fatty liver disease and steatohepatitis. Clin Liver Dis 8: 559-574, 2004.
39. PÉGORIER JP, LE MAY C, GIRARD J: Control of gene expression by fatty acids. J Nutr 134: 2444S-2449S, 2004.
40. PESSAYRE D: Role of mitochondria in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 22 (Suppl): S20-S27, 2007.
41. PILZ J, MEINEKE I, GLEITER CH: Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative. J Chromatogr B Biomed Sci Appl 742: 315-325, 2000.
42. POPELOVÁ O, ŠTĚRBA M, ŠIMŮNEK T, MAZUROVÁ Y, GUNČOVÁ I, HROCH M, ADAMCOVÁ M, GERŠL V: Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo. J Pharmacol Exp Ther 326: 259-269, 2008.
43. REEVES PG, NIELSEN FH, FAHEY GC JR: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951, 1993.
44. ROMESTAING C, PIQUET MA, BEDU E, ROULEAU V, DAUTRESME M, HOURMAND-OLLIVIER I, FILIPPI C, DUCHAMP C, SIBILLE B: Long term highly saturated fat diet does not induce NASH in Wistar rats. Nutr Metab (Lond) 4: 4, 2007.
45. ROMESTAING C, PIQUET MA, LETEXIER D, REY B, MOURIER A, SERVAIS S, BELOUZE M, ROULEAU V, DAUTRESME M, OLLIVIER I, FAVIER R, RIGOULET M, DUCHAMP C, SIBILLE B: Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet. Am J Physiol 294: E110-E119, 2008.
46. SATO N: Central role of mitochondria in metabolic regulation of liver pathophysiology. J Gastroenterol Hepatol 22 (Suppl): S1-S6, 2007.
47. SCHNEIDER WC, HOGEBOOM GH: Intracellular distribution of enzymes. V. Further studies on the distribution of cytochrome c in rat liver homogenates. J Biol Chem 183: 123-128, 1950.
48. SERVIDDIO G, BELLANTI F, TAMBORRA R, ROLLO T, CAPITANIO N, ROMANO AD, SASTRE J, VENDEMIALE G, ALTOMARE E: Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury. Gut 57: 957-965, 2008.
49. SVÁTKOVÁ R, ČERVINKOVÁ Z, KALOUS M, RAUCHOVÁ H, DRAHOTA Z: Respiratory control index of mitochondria isolated from regenerating rat liver. Physiol Res 45: 249-252, 1996.
50. TILG H: The role of cytokines in non-alcoholic fatty liver disease. Dig Dis 28: 179-185, 2010.
51. TURNER N, BRUCE CR, BEALE SM, HOEHN KL, SO T, ROLPH MS, COONEY GJ: Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56: 2085-2092, 2007.
52. VENDEMIALE G, GRATTAGLIANO I, CARACENI P, CARACCIO G, DOMENICALI M, DALL'AGATA M, TREVISANI F, GUERRIERI F, BERNARDI M, ALTOMARE E: Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status. Hepatology 33: 808-815, 2001.
53. YOSHIOKA S, HAMADA A, JOBU K, YOKOTA J, ONOGAWA M, KYOTANI S, MIYAMURA M, SAIBARA T, ONISHI S, NISHIOKA Y: Effects of Eriobotrya japonica seed extract on oxidative stress in rats with nonalcoholic steatohepatitis. J Pharm Pharmacol 62: 241-246, 2010.
54. ZHENG S, YUMEI F, CHEN A: De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation. Free Radic Biol Med 43: 444-453, 2007.
55. ZOU Y, LI J, LU C, WANG J, GE J, HUANG Y, ZHANG L, WANG Y: High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci 79: 1100-1107, 2006.